Is Tummy Trouble Keeping Your Child Out Of School? It Could Be Irritable Bowel Syndrome

VSL#3® Probiotic Shown Effective in Dietary Management of Children With Irritable Bowel Syndrome

‘It was a lightbulb moment,’ says Claire, from Billingshurst, West Sussex. Confessions of a workaholic: A stark warning form a City high flyer whose obsession with her demanding career led her to the brink… The symptoms of IBS are triggered when muscles in the large intestine become sensitised and contract. The underlying cause is unknown, but stress can be a trigger. ‘I realised Elliott’s problems had coincided with him starting full-time at school,’ says Claire. ‘He didn’t get on with his new teacher and that’s when it began. ‘Yet when we’d gone to Portugal in the school holidays, the symptoms disappeared. ‘It was a relief to realise that Elliott didn’t have some horrible illness, but a shock to find out there was no cure.’ While as many as one adult in three will suffer from IBS at some point, many don’t realise children can also be affected. Indeed, one study suggested that 20 per cent of children suffer from IBS symptoms. The peak ages are from four to 12. So how can parents tell if their child has a simple tummy ache or IBS? Surprising: The second most cited cause for school absence is IBS ‘Most children will have bowel upsets and tummy aches when they’re having a stressful time but it usually goes away,’ says Professor Nick Read, a gastroenterologist and adviser to the IBS Network.

read review http://www.dailymail.co.uk/health/article-2430193/Irritable-Bowel-Syndrome-cause-childs-tummy-trouble.html

Pediatric Irritable Bowel Syndrome Medication

Using this high concentration of several different strains of specially selected beneficial bacteria, VSL#3 provides an optimal composition of good bacteria, enhancing the health of the GI tract and aiding in dietary management of IBS. Each packet of VSL#3 contains 450 billion CFU. VSL#3 is a registered trademark of VSL Pharmaceuticals Inc. VSL#3 is a product that has been licensed from VSL Pharmaceuticals Inc. to Sigma-Tau Pharmaceuticals, Inc. for the U.S. territory. For more information, visit http://www.vsl3.com . About Sigma-Tau Pharmaceuticals, Inc. Sigma-Tau Pharmaceuticals, Inc. is a U.S.-based, wholly owned subsidiary of the sigma-tau Group, and is dedicated solely to the global development and commercialization of medicines for patients with rare diseases.

what google did to me http://www.reuters.com/article/2010/08/16/idUS104326+16-Aug-2010+PRN20100816

Surprising: The second most cited cause for school absence is IBS

WebMD may also personalize the Services and the advertising that registered users see on the WebMD Sites based on their interests. For example, you may see different articles and advertisements in different places on medscape.com based on information you have shared with WebMD such as your specialty, information that WebMD has obtained by observing your previous activity within the WebMD Professional Network, or information that WebMD has received from third party sources, as described in this Privacy Policy. Third Parties In addition to aggregate information (discussed previously), we each may each share some kinds of personally identifiable information with third parties as described below. Other Companies: We have strategic relationships with other companies who offer products and services through the Services. When you are interacting with one of these companies, a different privacy policy may apply and will be presented to you at such time. Companies and People Who Work for Us: We each contract with other companies and individuals to help us provide our respective services. For example, we may host some of our Professional Sites on another company’s computers, hire technical consultants to maintain any Web-based clinical tools, work with companies to remove repetitive information from customer lists, analyze data, provide marketing assistance (including assisting us in targeting our advertisements as described herein), or provide customer service or fulfillment services. In addition, if you are a healthcare professional, we may request that a third party validate your licensure status and other information against available databases of healthcare professionals. In order to provide these services, these other companies may have limited access to some of the personally identifiable information we maintain about users of our Services. We require all such companies to comply with the terms of this Privacy Policy, to limit their access to any personal information to the minimum necessary to perform their obligations, and not to use the information they may access for purposes other than fulfilling their responsibilities to us. Market Research: From time to time, we may invite you to participate in sponsored or unsponsored market research surveys as further described above. We may provide aggregate information from the survey results to third parties including the survey sponsor, if applicable. If you receive remuneration for participating in a sponsored survey, we may be required to provide the sponsor with personally identifiable information about you for its recordkeeping and regulatory reporting purposes.

this article http://emedicine.medscape.com/article/930844-medication

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: